http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002538124-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate | 2000-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002538124-A |
| titleOfInvention | Ophthalmic formulations containing mucin |
| abstract | (57) [Summary]nThe present invention discloses ophthalmic applications of mucins derived from mammalian milk or milk by-products. This mucin has been found to be of the MUC1 type, similar to the transmembrane mucin expressed on the surface of the human eye. The mucin-containing formulation described in this invention is in the form of an aqueous formulation, which can be instilled into the eye, or in which an object to be inserted into the eye, such as a contact lens, is pre-soaked or It can be stored or it can take the form of an ointment or a solid device inserted into the conjunctival sac. The disclosed formulations are used for the treatment of tear films and eye surface disorders associated with the signs and symptoms of dry eye. In addition, formulations using mucins are also effective in reducing symptoms of eye irritation, such as those caused by environmental conditions or contact lens wear. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007209370-A |
| priorityDate | 1999-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.